FDA issued a Warning Letter to Haw Par Healthcare Limited on 7/20/2010 for a previous inspection.
483 Haw Par Healthcare Mar 2019

483 Haw Par Healthcare Mar 2019

Justin Boyd FDA$119.00 - Available Now

FDA investigators audited the Haw Par Healthcare - Singapore, Singapore facility and issued inspectional observations (via FDA 483) on 01 Mar 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 01 Mar 2019
  • Location: Singapore, Singapore
  • FEI: 3001432470
Add To Cart